STMN1 and neoplasm: Previously, we preclinically evaluated Nb radiotracers against the ICPs PD-L1 and LAG-3, demonstrating specific tumor uptake and high contrast imaging of ICPs on cancer or immune cells in syngeneic tumor models (34–37).